Left heart bypass support with the Rotaflow Centrifugal Pump® as a bridge to decision and recovery in an adult

Since left heart bypass or biventricular circulatory assist with an extracorporeal centrifugal pump as a bridge to decision or recovery sometimes requires long-time support, the long-term durability of extracorporeal centrifugal pumps is crucial. The Rotaflow Centrifugal Pump ® (MAQUET Cardiopulmona...

Full description

Saved in:
Bibliographic Details
Published in:Journal of artificial organs 2012-06, Vol.15 (2), p.207-210
Main Authors: Kashiwa, Koichi, Nishimura, Takashi, Saito, Aya, Kubo, Hitoshi, Fukaya, Aoi, Tamai, Hisayoshi, Yambe, Tomoyuki, Kyo, Shunei, Ono, Minoru
Format: Article
Language:English
Subjects:
Aortic Valve Stenosis - surgery
Biomedical Engineering and Bioengineering
Cardiac Surgery
Case Report
Extracorporeal Membrane Oxygenation
Fatal Outcome
Female
Heart Bypass, Left
Heart-Assist Devices
Humans
Medicine
Medicine & Public Health
Middle Aged
Nephrology
Postoperative Complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since left heart bypass or biventricular circulatory assist with an extracorporeal centrifugal pump as a bridge to decision or recovery sometimes requires long-time support, the long-term durability of extracorporeal centrifugal pumps is crucial. The Rotaflow Centrifugal Pump ® (MAQUET Cardiopulmonary AG, Hirrlingen, Germany) is one of the centrifugal pumps available for long-term use in Japan. However, there have been few reports of left heart bypass or biventricular circulatory support over the mid-term. This is a case report of left heart bypass support with the Rotaflow Centrifugal Pump ® as a bridge to decision and recovery for an adult patient who could not be weaned from cardiopulmonary bypass and percutaneous cardiopulmonary support after cardiac surgery. We could confirm that the patient’s consciousness level was normal; however, the patient could not be weaned from the left heart bypass support lasting 1 month. Therefore, the circulatory assist device was switched to the extracorporeal Nipro ventricular assist device (VAD). This time, left heart bypass support could be maintained for 30 days using a single Rotaflow Centrifugal Pump ® . There were no signs of hemolysis during left heart bypass support. The Rotaflow Centrifugal Pump ® itself may be used as a device for a bridge to decision or recovery before using a VAD in cardiogenic shock patients.
ISSN:1434-7229
1619-0904
DOI:10.1007/s10047-012-0632-x